Pharmacogenomics

Results: 201



#Item
51Iris Grossman, PhD Carbernet Pharmaceuticals, Inc. Durham, NC, USA Iris Grossman, Director, Pharmacogenetics, at Cabernet, has focused her research

Iris Grossman, PhD Carbernet Pharmaceuticals, Inc. Durham, NC, USA Iris Grossman, Director, Pharmacogenetics, at Cabernet, has focused her research

Add to Reading List

Source URL: epmanet.eu

Language: English - Date: 2012-12-17 17:31:13
52Romano Danesi, MD, PhD University of Pisa +Pharmacogenomics is strategic companion in current clinical development of novel

Romano Danesi, MD, PhD University of Pisa +Pharmacogenomics is strategic companion in current clinical development of novel

Add to Reading List

Source URL: epmanet.eu

Language: English - Date: 2012-12-17 17:26:46
53Dr Godfrey Grech Following his Science degree at the University of Malta in 1994, Dr Godfrey Grech pursued his studies at a Masters level in the Faculty of Medicine specialising in Molecular Genetics. In 2002, he starte

Dr Godfrey Grech Following his Science degree at the University of Malta in 1994, Dr Godfrey Grech pursued his studies at a Masters level in the Faculty of Medicine specialising in Molecular Genetics. In 2002, he starte

Add to Reading List

Source URL: epmanet.eu

Language: English - Date: 2013-08-05 04:30:31
54Honours Projects 2014 – Pharmacology Pharmacogenomics in the treatments of: Acute surgical pain and Chronic cancer pain Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Honours Projects 2014 – Pharmacology Pharmacogenomics in the treatments of: Acute surgical pain and Chronic cancer pain Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Add to Reading List

Source URL: health.adelaide.edu.au

Language: English - Date: 2013-09-25 02:05:53
55Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

Add to Reading List

Source URL: health.adelaide.edu.au

Language: English - Date: 2013-09-25 02:05:52
56Pharmacogenomics: Implications for palliative care practice

Pharmacogenomics: Implications for palliative care practice

Add to Reading List

Source URL: www.health.qld.gov.au

Language: English - Date: 2013-10-24 01:31:14
57Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Add to Reading List

Source URL: www.coriell.com

Language: English - Date: 2013-12-12 15:08:51
58REVIEW Cytochrome P450 Part 2: Genetics of Inter-Individual Variability Michael B Ward, Michael J Sorich, Ross A McKinnon Poor

REVIEW Cytochrome P450 Part 2: Genetics of Inter-Individual Variability Michael B Ward, Michael J Sorich, Ross A McKinnon Poor

Add to Reading List

Source URL: jppr.shpa.org.au

Language: English - Date: 2008-09-28 21:38:48
59professional Pharmacogenomics Raktim Ghosh Samhati Ghosh Shalini Chawla

professional Pharmacogenomics Raktim Ghosh Samhati Ghosh Shalini Chawla

Add to Reading List

Source URL: www.racgp.org.au

Language: English - Date: 2012-10-09 01:09:51
60Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Add to Reading List

Source URL: genomemedicine.com

Language: English